Background & Aims: Interleukin 1 beta (IL-beta) and tumor necrosis fac
tor alpha (TNF-alpha) are present in the neuromuscular layers during i
ntestinal inflammation and directly affect intestinal smooth Muscle fu
nction. We investigated whether IL-1 beta and TNF-alpha modulate T-cel
l activation by murine intestinal smooth muscle cells (ISMCs), Methods
: alpha- and gamma-actin expression in ISMCs was confirmed using rever
se-transcription polymerase chain reaction (FIT-PCR), ISMCs were analy
zed for class II major histocompatibility complex (MHC), intercellular
adhesion molecule 1 (ICAM-1), and B7 before and after exposure to int
erferon gamma (IFN-gamma; 100 or 1000 U/mL) in the presence or absence
of IL-1 beta (10 ng/mL) or TNF-alpha (5 ng/mL) for 72 hours. T-cell p
roliferation on cytokine-pretreated ISMCs was measured in the absence
or presence of anti-B7 antibodies, Results: In a dose-dependent fashio
n, IFN-gamma-pretreated ISMCs expressed MHC class II, ICAM-1, and B7-2
, and simulated T-cell proliferation. Pretreatment of ISMCs with IL-1
beta and IFN-gamma reduced MHC class II acid ICAM-1 expression and inh
ibited T-cell proliferation, When added with 100 U/mL IFN-gamma, TNF-a
lpha enhanced MHC class II and ICAM-1 expression on ISMCs and T-cell p
roliferation. However, TNF-alpha and 1000 U/mL IFN-gamma significantly
decreased MHC class II expression and T-cell proliferation. Anti-B7-2
monoclonal antibody but not anti-B7-1 inhibited T-cell proliferative
responses by >50%, Conclusions: Because IL-1 beta, TNF-alpha, and T ce
lls are present in the intestinal muscle layers during inflammation, t
hese cytokines may serve to modulate the activation of T cells in this
site.